Ven, I think the PR was poorly written and did not address the advantages of the 2-73 only treatment. Readers had to go to the graphs to figured that out for themselves, which in all the electricity going on with the SP took some time to focus on that.
Lack of awareness on the PR firm and Anavex as to the case that should have been made, regardless of the 2-73 only group's size.